Peptinovo Biopharma
San Diego, United States· Est. 2018
We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.
Private Company
Funding information not available
About
We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.
Drug Delivery